Osteoporosis Drug Market Projected to Reach $17.2 Billion by 2030, Dominated by North American Region
January 23, 2024 02:58 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis Drug Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Postmenopausal Osteoporosis Pipeline Research Report 2023: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs
November 22, 2023 09:03 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Postmenopausal osteoporosis - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
Global Osteoporosis Drugs Market to Reach $17.52 Billion by 2030
September 06, 2023 10:03 ET
|
Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Osteoporosis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report...
Global Osteoporosis Disease Analysis Market Report 2020: Novartis has the Highest Number of Completed Clinical Trials for Osteoporosis with 120 Trials
February 01, 2021 06:38 ET
|
Research and Markets
Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Osteoporosis" report has been added to ResearchAndMarkets.com's offering. Osteoporosis is the most common metabolic bone disease, and...
United States Osteoporosis Market and Competitive Landscape Report 2021
January 19, 2021 04:38 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Osteoporosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Osteoporosis Market and...